TVTX

NASDAQStock

Travere Therapeutics, Inc.

$27.36-0.19 (-0.69%)

52-Week Range

$13.49

$40.28

Key Stats

Market Cap

2.5B

P/E Ratio

—

Dividend Yield

—

Beta

0.88

Volume

369.3K

Avg Volume

1.4M

Performance

-0.97%

-20.74%

+20.99%

YTD

-30.29%

+32.01%

+28.80%

-0.36%

Price Chart

ETF Exposure

TVTX is held by 111 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	724	$20K	$1.43B	0.09%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	138	$6K	$820.6M	0.25%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	3	$88	$8.9M	0.30%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	7	$197	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	23	$652	$80.3M	0.10%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	2,255	$63K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	2,255	$63K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	2,255	$63K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	2,255	$63K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	2,255	$63K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	23	$1K	$337.7M	0.32%

PreviousPage 3 of 3

About TVTX ETF Exposure

Travere Therapeutics, Inc. (TVTX) is held by 111 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.5B, TVTX is a widely held institutional stock. The stock currently trades at $27.36. Investors can gain exposure to TVTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TVTX, sorted by portfolio weight.